NEW YORK (GenomeWeb News) – Bioinformatics firm Maverix Biomics today announced it raised $6 million in a Series A financing round to support the continued commercialization of its recently launched data analysis platform.

The financing was led by Asset Management Ventures and individual investors Andreas Bechtolsheim and Andrew Yang. In conjunction with the financing, Yang and Louis Lange, a general partner at Asset Management, have joined Maverix's board.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.

Jun
23
Sponsored by
PerkinElmer

This webinar will demonstrate how automated liquid handling workstations can reduce bottlenecks in library preparation for next-generation sequencing, enabling scientific advances in genomics research that were not possible five years ago.